FDA Import Refusal AEK-9183261-5/11/1 — Abbvie Ltd
The FDA refused shipment AEK-9183261-5/11/1 from Abbvie Ltd (United Kingdom) on Jun 3, 2021. The refused product falls under Drugs and Biologics — ADALIMUMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 3, 2021
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61YCY02 ADALIMUMAB
- Charges
- 75